Korian completes its transformation into a purpose-driven company

Clariane Group

Korian launched a vast consultation in February 2022 to define its purpose and impact. All employees, as well as more than 1,500 patients, residents and family carers, associations, public officials, local authorities and investors, participated in the consultation.

As a result of this consultation, the Group is proposing to include in its articles of association a new purpose, common to all its activities: Take care of each person’s humanity in times of vulnerability.

The process of transforming into a purpose driven company has mobilised the entire Korian community and I would like to thank the stakeholders for their very rich contributions, which are a testament to the importance of our day-to-day role in the heart of our communities as well as showing the strong convergence of expectations and priorities of the different stakeholders.

Through the initiatives we are going to deploy, our ambition is to strengthen the relationship between patients and caregivers. We believe that we can create a positive impact through our commitment to support the health of our employees, their career advancement through training and by working closely with the local communities in each country. I am counting on the Mission Committee to enhance the quality of dialogue with our stakeholders and I am delighted that Dr Françoise Weber, who set up the Korian France Stakeholder Council, has agreed to chair it.

Sophie Boissard Chief Executive Officer and Director